ORYZF News Today: Stay Updated with the Latest Oryzon Genomics S.A. News in Real Time
Find ORYZF news now at Meyka AI. Stay informed with the latest Oryzon Genomics S.A. stocks updates, including price news, market analysis, and expert insights.
MYGN Director Bisaro Paul Buys 7,500 Shares on May 14, 2026
Myriad Genetics director Bisaro Paul purchased 7,500 shares at $3.69 per share on May 14, 2026, signaling insider confidence in MYGN stock.
IntegraGen SA Stock Tumbles 28% as Biotech Faces Profitability Headwinds
ALINT.PA stock crashes 28.3% on weak fundamentals. Genomics firm reports negative earnings, cash burn, and Meyka AI rates it a HOLD with C grade.
Oryzon Genomics Climbs 0.43% as Iadademstat Shows 100% Response Rate
ORY.MC stock rises on positive iadademstat clinical data showing 100% overall response rate in acute myeloid leukemia trials.
ALINT.PA stock surges 15% in pre-market as volume spikes on May 13
IntegraGen SA (ALINT.PA) jumps 15.13% in pre-market trading with volume 3x average. Biotech stock shows strong momentum on EURONEXT.
ALINT.PA stock surges 45% on high volume trading May 8
ALINT.PA stock jumps 45% with 86,552 shares traded. IntegraGen SA genomics services drive volume surge on EURONEXT.
TECN.SW stock surges 6.32% in pre-market trading on May 7
TECN.SW stock jumps 6.32% to CHF132.9 in pre-market session. Tecan Group AG shows strong volume activity on SIX exchange.
NTRA Earnings Preview: Natera Q1 2026 on May 7
Natera earnings preview: Analysts expect -$0.53 EPS and $617M revenue on May 7. Stock down 2.3% ahead of report.
DAP.DE Danaher Earnings Beat: EPS Tops Estimates
Danaher (DAP.DE) beat EPS estimates with $1.78 vs $1.68 expected, but revenue missed at $5.15B. Stock down 1.2% post-earnings.
DAP.DE Danaher Earnings: April 2026 Recap
Danaher Corporation (DAP.DE) reported earnings on April 20, 2026. Stock trades at €166.90 with €116.27B market cap. Meyka AI rates B.